Improving wound-healing outcomes in diabetic foot ulcers

References

• Abbott RD, Brand FN, Kannel WB. Epidemiology of some peripheral arterial findings in diabetic men and women; experiences from the Framingham Study. Am. J. Med.88, 376–381 (1990).
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Kirsner RS, Vileikyte L. Neuropathic diabetic foot ulcers. N. Engl. J. Med.351, 48–55 (2004).
   PubMed Web of Science ®Google Scholar
• Cunha BA. Antibiotic selection for diabetic foot infections: a review. J. Foot Ankle Surg.39, 253–257 (2000).
   PubMedGoogle Scholar
• Frykberg RG. An evidence-based approach to diabetic foot infections. Am. J. Surg.186, 44–54 (2003).
   Web of Science ®Google Scholar
• Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care13, 513–521 (1990).
   PubMed Web of Science ®Google Scholar
• Reiber GE, (Ed). The Diabetic Foot. St. Louis; Mosby. 13–32 (2001).
   Google Scholar
• Reiber GE, Boyko E, Smith DG. Lower Extremity ulcers and amputations in individuals with diabetes. I, National Institute of Health, Bethesda, MD. Editorial. Putting feet first in diabetes. Lancet366, 1674 (2005).
   Google Scholar
• Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet366, 1725–1735 (2005).
   PubMed Web of Science ®Google Scholar
• Aksoy DY, Gurlek A, Cetinkaya Y et al. Change in the amputation profile in diabetic foot in a tertiary reference center: efficacy of team working. Exp. Clin. Endocrinol. Diabetes112, 526–530 (2004).
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. I. Preventive foot care in people with diabetes. Diabetes Care25, S69–S70 (2002).
   Google Scholar
• International Diabetes Federation. Diabetes Altas, 2nd Edition (2003).
   Google Scholar
• Vileikyte L, Rubin RR, Leventhal H. Psychological aspects of diabetic neuropathic foot complications: an overview. Diabetes Metab. Res. Rev.20, S13–S18 (2004).
   Google Scholar
• Edmonds ME, Blundell MP, Morris ME, Thomas EM, Cotton LT, Watkins PJ. Improved survival of the diabetic foot: the role of a specialized foot clinic. Q. J. Med.60, 763–771 (1986).
   PubMedGoogle Scholar
• Foster AV. Is there an evidence base for diabetic foot care? J. Tissue Viability12, 113–117 (2002).
   Google Scholar
• Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. The Seattle Diabetic Foot Study. Diabetes Care22, 1036–1042 (1999).
   PubMed Web of Science ®Google Scholar
• Frykberg RG, Lavery LA, Pham H, Harvey C, Harkless L, Veves A. Role of neuropathy and high foot pressure in diabetic foot ulceration. Diabetes Care21, 1714–1719 (1998).
   PubMed Web of Science ®Google Scholar
• Perkins B, Olaleye D, Zinman B, Bril V. Simple screening tests for peripheral neuropathy in the diabetes clinic. Diabetes Care24, 250–256 (2001).
   PubMed Web of Science ®Google Scholar
• Young MJ, Cavanagh PR, Thomas G et al. The effect of callus removal on dynamic plantar foot pressures in diabetic patients. Diabet. Med.9, 55–57 (1992).
   Web of Science ®Google Scholar
• Kumar S, Fernando DJS, Veves A et al. Semmes Weinstein monfilaments: a simple, effective and inexpensive screening device for identifying patients at risk of foot ulceration. Diabetes Res. Clin. Pract.13, 63–68 (1991).
   PubMed Web of Science ®Google Scholar
• Young MJ, Breddy JL, Veves A, Boulton AJ. The prediction of diabetic neuropathic foot ulceration using vibration perception thresholds. A prospective study. Diabetes Care17, 557–560 (1994).
   PubMed Web of Science ®Google Scholar
• Boulton AJM, Gries FA, Jervell JA. Guidelines for the diagnosis and outpatient management of diabetic peripheral neuropathy. Diabet. Med.15, 508–514 (1998).
   PubMed Web of Science ®Google Scholar
• Brem H, Sheehan P, Boulton AJM. Protocol for treatment of diabetic foot ulcers. Am. J. Surg.187, S1–S10 (2004).
   PubMedGoogle Scholar
• McGill M, Molyneaux L, Yue DK. Which diabetic patients should receive podiatry care? An objective analysis. Intern. Med. J.35, 451–456 (2005).
   Google Scholar
• Smith J. Debridement of diabetic foot ulcers (review). Cochrane Database Syst. Rev.3 (2005).
   Google Scholar
• Murray HJ, Young MJ, Hollis S, Boulton AJ. The association between callus formation, high pressures and neuropathy in diabetic foot ulceration. Diabet. Med.13, 979–982 (1996).
   PubMed Web of Science ®Google Scholar
• Potter J, Potter MJ. Effect of callus removal on peak plantar pressures. The Foot10, 23–26 (2000).
   Google Scholar
• Bradley M, Cullum N, Sheldon T. The debridement of chronic wounds; a systematic review. Health Technol. Assess.3, 1–78 (1999).
   PubMedGoogle Scholar
• Guzman B, Fisher G, Palladino SJ, Stavosky JW. Pressure-removing strategies in neuropathic ulcer therapy. An alternative to total contact casting. Clin. Podiatr. Med. Surg.11, 339–353 (1994).
   Google Scholar
• Lavery LA, Baranoski S, Ayello EA. Options for off-loading the diabetic foot. Adv. Skin Wound Care17(4 Pt 1), 181–182; Review: 184–186 (2004).
   Google Scholar
• Hartsell HD, Brand RA, Frantz RA, Saltzman CL. The effects of total contact casting materials on plantar pressures. Foot Ankle Int.25, 73–78 (2004).
   PubMed Web of Science ®Google Scholar
• Sieggreen MY, Kline RA. Arterial insufficiency and ulceration:diagnosis and treatment options. Nurse Pract.29(9), 46–52(2004).
   Google Scholar
• Lipsky BA, Berendt AR, Gunner Deery H et al. Diagnosis and treatment of diabetic foot infections. J. Am.Podiatr. Med. Assoc.95, 183–210 (2005).
   Google Scholar
• Peters E, Lavery L, Armstrong D. Diabetic lower extremity infections, influence of physical, psychological, and social factors. J. Diabetes Complicat.19, 107–112 (2005).
   Web of Science ®Google Scholar
• Jeffcoate WJ, Price P, Harding KG. Wound healing and treatments for people with diabetic foot ulcers. Diabetes Metab. Res. Rev.20, S78–S89 (2004).
   PubMed Web of Science ®Google Scholar
• Edmonds M. Early use of antibiotics should not be ruled out. The Diabetic Foot2, 135–138 (1999).
   Google Scholar
• Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. Cytokine8, 548–556 (1996).
   PubMed Web of Science ®Google Scholar
• Goldman R. Growth factors and chronic wound healing, past, present, and future. Adv Skin Wound Care17, 24–35 (2004).
   PubMedGoogle Scholar
• O’Kane S, Ferguson MW. Transforming growth factor β and wound healing. Int. J. Biochem. Cell Biol.29, 63–78 (1997).
   PubMed Web of Science ®Google Scholar
• Leask A, Abraham DJ. TGF-β signaling and the fibrotic response. Fed. Am. Soc. Exp. Biol. J.18, 816–817 (2004).
   PubMed Web of Science ®Google Scholar
• Brown RL, Breeden MP, Greenhalgh DG. PDGF and TGF-α act synergistically to improve wound healing in the genetically diabetic mouse. J. Surg. Res.56, 562–570 (1994).
   PubMed Web of Science ®Google Scholar
• Loots MA, Lamme EN, Mekkes JR, Bos JD, Middelkoop E. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation. Arch. Dermatol. Res.291, 93–99 (1999).
   PubMed Web of Science ®Google Scholar
• da Costa Pinto FA, Malucelli BE. Inflammatory infiltrate, VEGF and FGF-2 contents during corneal angiogenesis in STZ-diabetic rats. Angiogenesis5, 67–74 (2002).
   PubMedGoogle Scholar
• Chesnoy S, Lee PY, Huang L. Intradermal injection of transforming growth factor-β1 gene enhances wound healing in genetically diabetic mice. Pharm. Res.20, 345–350 (2003).
   PubMed Web of Science ®Google Scholar
• Loots MA, Lamme EN, Zeegelaar J, Mekkes JR, Bos JD, Middelkoop E. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J. Invest. Dermatol.111, 850–857 (1998).
   PubMed Web of Science ®Google Scholar
• Ferguson MW, Herrick SE, Spencer MJ, Shaw JE, Boulton AJ, Sloan P. The histology of diabetic foot ulcers. Diabet. Med.13(Suppl. 1), S30–S33 (1996).
   PubMedGoogle Scholar
• Bitar MS, Labbad ZN. Transforming growth factor-β and insulin-like growth factor-I in relation to diabetes-induced impairment of wound healing. J. Surg. Res.61, 113–119 (1996).
   PubMed Web of Science ®Google Scholar
• Falanga V. Wound healing and its impairment in the diabetic foot. Lancet366, 1736–1743 (2005).
   PubMed Web of Science ®Google Scholar
• Lerman OZ, Galiano RD, Armour M, Levine JP, Gurtner GC. Cellular dysfunction in the diabetic fibroblast: impairment in migration, vascular endothelial growth factor production, and response to hypoxia. Am. J. Pathol.162, 303–312 (2003).
   PubMed Web of Science ®Google Scholar
• Signorelli SS, Malaponte G, Libra M et al. Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in Type II diabetics with peripheral arterial disease. Vasc. Med.10, 1–6 (2005).
   PubMed Web of Science ®Google Scholar
• Jeffcoate W. The structure of foot ulcer trials: choice of outcome measures. The Diabetic Foot7, 8–12 (2004).
   Google Scholar
• Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet361, 1545–1551 (2003).
   PubMed Web of Science ®Google Scholar
• Smiell JM, Wieman TJ, Steed DL, Perry BH, Sampson AR, Schwab BH. Efficacy and safety of becaplermin (recombinant human platelet derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen.7, 335–346 (1999).
   PubMed Web of Science ®Google Scholar
• Wieman TJ, Smiell JM, Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor BB (becaplermin) in patients with chronic neuropathic ulcers. A Phase III randomized placebo-controlled double blind study. Diabetes Care21, 822–827 (1998).
   PubMed Web of Science ®Google Scholar
• Tsang MW, Wong WK, Hung CS, Lai KM, Tang W et al. Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care26, 1856–1861 (2003).
   PubMed Web of Science ®Google Scholar
• Mustoe TA, Pierce GF, Morishima C, Deuel TF. Growth factor induced acceleration of tissue repair through direct and inductive activities. J. Clin. Invest.87, 694–703 (1991).
   PubMed Web of Science ®Google Scholar
• Keswani SG, Katz AB, Lim FY, Zoltick P, Radu A et al. Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen.12, 497–504 (2004).
   PubMed Web of Science ®Google Scholar
• Deodato B, Arsic N, Zentilin L et al. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther.9(12), 777–785 (2002).
   PubMed Web of Science ®Google Scholar
• Galeano M, Deodato B, Altavilla D et al. Effect of recombinant adeno-associated virus vector-mediated vascular endothelial growth factor gene transfer on wound healing after burn injury. Crit. Care Med.31, 1017–1025 (2003).
   PubMed Web of Science ®Google Scholar
• Romano Di, Peppe S, Mangoni A et al. Adenovirus-mediated VEGF(165) gene transfer enhances wound healing by promoting angiogenesis in CD31 diabetic mice. Gene Ther.19, 1271–1277 (2002).
   Google Scholar
• Kawai K, Suzuki S, Tabata Y, Nishimura Y. Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure-induced decubitus ulcer model in genetically diabetic mice. Br. J. Plast. Surg.58, 1115–1123 (2005).
   PubMedGoogle Scholar
• Obara K, Ishihara M, Fujita M et al. Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2. Wound Repair Regen.13, 390–397 (2005).
   PubMed Web of Science ®Google Scholar
• Gohari S, Gambla C, Healey M et al. Evaluation of tissue-engineered skin (human skin substitute) and secondary intention healing in the treatment of full thickness wounds after Mohs micrographic or excisional surgery. Dermatol. Surg.28, 1107–1114 (2002).
   PubMed Web of Science ®Google Scholar
• Mansbridge J. Skin substitutes to enhance wound healing. Expert Opin. Investig. Drugs7, 803–809 (1998).
   PubMedGoogle Scholar
• Veves A, Falanga V, Armstrong DG, Sabolinski ML, Study ADFU. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care.24, 290–295 (2001).
   PubMed Web of Science ®Google Scholar
• Marston WA. Dermagraft, a bioengineered human dermal equivalent for the treatment of chronic nonhealing diabetic foot ulcer. Expert Rev. Med. Devices1, 21–31 (2004).
   PubMed Web of Science ®Google Scholar
• Marston WA, Hanft J, Norwood P, Pollak R. Dermagraft Diabetic Foot Ulcer Study Group. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care.26(6), 1701–1705 (2003).
   PubMed Web of Science ®Google Scholar
• Marston WA, Usala A, Hill RS, Mendes R, Minsley MA. Initial report of the use of an injectable porcine collagen-derived matrix to stimulate healing of diabetic foot wounds in humans. Wound Repair Regen.13, 243–247 (2005).
   PubMed Web of Science ®Google Scholar
• Loomans CJ, de Koning EJ, Staal FJ et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of Type 1 diabetes. Diabetes53, 195–199 (2004).
   PubMed Web of Science ®Google Scholar
• Asahara T, Takahashi T, Masuda H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J.18, 3964–3972 (1999).
   PubMed Web of Science ®Google Scholar
• Sivan-Loukianova E, Awad OA, Stepanovic V, Bickenbach J, Schatteman GC. CD34+ blood cells accelerate vascularization and healing of diabetic mouse skin wounds. J. Vasc. Res.40, 368–377 (2003).
   PubMed Web of Science ®Google Scholar
• Badiavas EV, Falanga V. Treatment of chronic wounds with bone marrow-derived cells. Arch. Dermatol.139, 510–516 (2003).
   PubMed Web of Science ®Google Scholar
• Roeckl-Weidmann I, Bennett M, Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br. J. Surg.92, 24–32 (2005).
   Google Scholar
• Kessler L, Bilbaut P, Ortega F et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers. Diabetes Care26, 2378–2382 (2003).
   PubMed Web of Science ®Google Scholar
• Abidia A, Laden G, Kuhan G et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur. J. Vasc. Endovasc. Surg.25, 513–518 (2003).
   PubMed Web of Science ®Google Scholar
• Cullum N, Nelson EA, Flemming K, Sheldon T. Systematic reviews of wound care management: (5) beds; (6) compression; (7) laser therapy, therapeutic ultrasound, electrotherapy and electromagnetic therapy. Health Technol. Assess.5, 1–221 (2001).
   PubMedGoogle Scholar
• Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet366, 1704–1710 (2005).
   PubMed Web of Science ®Google Scholar
• Stechmiller JM, Kilpadi DV, Childress BS, Schultz GS. Effect of Vacuum-Assisted Closure therapy on the expression of cytokines and proteases in wound fluid of adults with pressure ulcers. Wound Repair Regen.14, 371–374 (2006).
   Google Scholar